Assessing depression and factors possibly associated with depression during the course of Parkinson's disease.
Ann Clin Psychiatry., Aug;23(3):171-7 (2011)
Plasma beta-amyloid linked to cognitive decline.
Arch. Neurol., Jun;68(6):799-801 (2011)
Effects of simvastatin on cholesterol metabolism and Alzheimer disease biomarkers.
Alzheimer Dis Assoc Disord., 24(3):220-6 (2010)
Beneficial effect of human anti-amyloid-beta active immunization on neurite morphology and tau pathology.
Brain., May;133(Pt 5):1312-27 (2010)
Molecular markers of early Parkinson's disease based on gene expression in blood.
Proc. Natl. Acad. Sci. U.S.A., Jan;104(3):955-60 (2007)
Molecular imaging with Pittsburgh Compound B confirmed at autopsy: a case report.
Arch. Neurol., Mar;64(3):431-4 (2007)
Increase in the relative expression of tau with four microtubule binding repeat regions in frontotemporal lobar degeneration and progressive supranuclear palsy brains.
Acta Neuropathol., Nov;114(5):471-9 (2007)
Analysis of feature space for monitoring persons with Parkinson's disease with application to a wireless wearable sensor system.
Conf Proc IEEE Eng Med Biol Soc., 2007:6291-4 (2007)
TAR-DNA binding protein 43 in Pick disease.
J. Neuropathol. Exp. Neurol., Jan;67(1):62-7 (2008)
Plasma amyloid beta-protein and C-reactive protein in relation to the rate of progression of Alzheimer disease.
Arch. Neurol., Jun;65(6):776-85 (2008)
Long-term course and effectiveness of combination therapy in Alzheimer disease.
Alzheimer Dis Assoc Disord., 22(3):209-21 (2008)
Replication of association between ELAVL4 and Parkinson disease: the GenePD study.
Hum. Genet., Aug;124(1):95-9 (2008)
The cortical signature of Alzheimer's disease: regionally specific cortical thinning relates to symptom severity in very mild to mild AD dementia and is detectable in asymptomatic amyloid-positive individuals.
Cereb. Cortex., Mar;19(3):497-510 (2009)
Huntington CAG repeat size does not modify onset age in familial Parkinson's disease: the GenePD study.
Mov. Disord., Aug;23(11):1596-601 (2008)
Imaging amyloid deposition in Lewy body diseases.
Neurology., Sep;71(12):903-10 (2008)
Incorporating biomarkers into clinical drug trials in Alzheimer's disease.
J. Alzheimers Dis., Jun;3(3):287-292 (2001)
Relation between clinical characteristics of Parkinson's disease and cognitive decline.
J Clin Exp Neuropsychol., Feb;25(1):94-109 (2003)
Working memory in mild Alzheimer's disease and early Parkinson's disease.
Neuropsychology., Apr;17(2):230-9 (2003)
Age but not diagnosis is the main predictor of plasma amyloid beta-protein levels.
Arch. Neurol., Jul;60(7):958-64 (2003)
Effects of normal aging and Alzheimer's disease on emotional memory.
Emotion., Jun;2(2):118-34 (2002)